
The company's semaglutide-based weight-loss drugs will be made available in the US through Medicare and Medicaid

The agreement will make insulin and obesity treatments more affordable through federal programmes and direct-to-patient channels

Approximately 7,700 people in England are living with the genetic bleeding disorder

The factor VIII replacement therapy has been authorised to treat and prevent bleeding in children and adults

The inherited bleeding disorder accounts for up to 85% of the 1,125,000 global haemophilia cases

Heather Wellam (Senior Consultant – Market Access, Mtech Access) explores the concept of willingness to pay (WTP) and what it means for pharmaceutical and medtech pricing strategy. Read on to...

The rare bleeding disorder occurs in approximately 25 in every 100,000 male births globally

The rare bleeding disorder affects approximately one in every 5,000 male births annually

The inherited bleeding disorder accounts for up to 85% of the 1,125,000 global haemophilia cases

The rare bleeding disorder affects approximately one in every 5,000 male births annually

The therapy’s weekly dosing has a half-life of up to four times longer than current factor VIII therapies

Haemophilia A accounts for up to 85% of the 1,125,000 global haemophilia cases